Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab
Abraham Boskovitz, Roger E. McLendon, Tatsunori Okamura, John H. Sampson, Darell D. Bigner, Michael R. ZalutskyVolume:
36
Year:
2009
Language:
english
DOI:
10.1016/j.nucmedbio.2009.04.003
File:
PDF, 590 KB
english, 2009